BMT Tandem "Scientific" Meeting
Ballroom E-H (Salt Palace Convention Center)
Chairs:
Kirsten M Williams, MD
and
Geoff Hill, MD
Summary:
Abstracts: #2699, 2417, 2141, 2121, 2353, 2659
Increased Blnk and Syk in B Cells From Chronic Graft-Versus-Host Disease Patients: Identification of Novel Therapeutic Targets
Jessica L Allen, PhD, University of North Carolina;
George Fedoriw, MD, University of North Carolina School of Medicine;
Jenna Wooten, PhD, University of North Carolina;
Matthew Fore, University of North Carolina;
Philip A Roehrs, MD, University of North Carolina School of Medicine;
Paul Armistead, MD, PhD, Univeristy of North Carolina;
James Coghill, MD, University of North Carolina School of Medicine;
Thomas C. Shea, MD, University of North Carolina at Chapel Hill;
Kristy Richards, MD, PhD, University of North Carolina;
Stephanie J. Lee, MD, MPH, Fred Hutchinson Cancer Research Center;
Krista Rowe, RN, MSN, AOCNS, Duke University Health System;
David Rizzieri, M.D., Duke Universtiy Medical Center;
Nelson J. Chao, MD, Duke University Medical Center;
Jonathan S. Serody, MD, University of North Carolina;
Stefanie Sarantopoulos, MD, PhD, University of North Carolina
A Multi-Center, Randomized, Double Blind, Phase III Clinical Trial Comparing Steroids/Placebo Vs. Steroids/Mycophenolate Mofetil As Initial Therapy for Acute Graft-Versus-Host Disease. Blood and Marrow Transplant Clinical Trials Network Study 0802
Javier Bolaños-Meade, MD, Johns Hopkins University;
Brent R. Logan, PhD, Medical College of Wisconsin;
Amin M. Alousi, MD, University of Texas M.D. Anderson Cancer Center;
Joseph H Antin, MD, Dana-Farber Cancer Institute;
Kate Barowski, Emmes Corporation;
Shelly L Carter, ScD, The EMMES Corporation;
Elizabeth O. Hexner, MD, University of Pennsylvania;
Mary M. Horowitz, MD, MS, CIBMTR/Medical College of Wisconsin;
John E Levine, M.D., M.S., University of Michigan;
Margaret L. MacMillan, MD, MSc, University of Minnesota;
Paul J Martin, MD, Fred Hutchinson Cancer Research Center;
Ryotaro Nakamura, MD, City of Hope;
Marcelo C. Pasquini, MD, MS, CIBMTR/Medical College of Wisconsin;
Daniel J. Weisdorf, MD, University of Minnesota;
Peter Westervelt, MD, PhD, Washington University School of Medicine;
Vincent T. Ho, MD, Dana-Farber Cancer Institute
Prospective Evaluation of A ‘Two-Pronged' Strategy of Atorvastatin Administration As Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis, to Both Donors and Recipients of Matched Related Donor (MRD) Allogeneic Hematopoietic Cell Transplantation (alloHCT)
Mehdi Hamadani, MD, West Virginia University - Mary Babb Randolph Cancer Center;
Laura F Gibson, West Virginia University;
Scot C Remick, West Virginia University;
William Petros, West Virginia University;
Jame Abraham, West Virginia University;
Soumit Basu, West Virginia University;
William Tse, West Virginia University;
Aaron Cumpston, PharmD, West Virginia University Hospitals;
Pam Bunner, M.T., West Virginia University Hospitals - MBRCC;
Michael Craig, MD, West Virginia University
A Combination of Clinical Characteristics and Day 7 Biomarker Concentrations Predicts Graft-Versus-Host Disease Following Hematopoietic Cell Transplantation From Related Donors
Andrew C. Harris, M.D., University of Michigan;
James L.M. Ferrara, M.D., D.Sc., University of Michigan;
Thomas Braun, Ph.D., University of Michigan;
Daniel R. Couriel, M.D., University of Michigan;
Sung Choi, M.D., University of Michigan;
Carrie L. Kitko, M.D., University of Michigan;
Steven C. Goldstein, M.D., University of Michigan;
John Magenau, M.D., University of Michigan;
Sophie Paczesny, M.D., Ph.D., University of Michigan;
Attaphol Pawarode, M.D., University of Michigan;
Pavan Reddy, M.D., University of Michigan;
Gregory Yanik, M.D., University of Michigan;
Austin Taylor, University of Michigan;
James A Connelly, M.D., University of Michigan;
Craig A Byersdorfer, M.D., Ph.D., University of Michigan;
John E Levine, M.D., M.S., University of Michigan
Synergistic Control of Acute GvHD: Effectively Down-Regulating T Cell Proliferation and Cytotoxicity with Combined mTOR Inhibition and CD28:CD80/86 Costimulation Blockade
Natalia Kozyr, Emory University;
Swetha Ramakrishnan, Emory University;
Aneesah Polnett, Emory University;
Kelly Hamby, Emory University;
Divya Tiwari, Emory University;
Benjamin Watkins, Emory University;
Taylor Deane, Emory University;
Linda Stempora, Emory University;
Eric Elder, Emory University;
Natia Esiashvili, Emory University Hospital;
Joe Jenkins, Emory University;
Elizabeth Strobert, Emory University;
Anapatricia Garcia, Emory University;
Prachi Sharma, Emory University;
Cynthia Courtney, Emory University;
Cynthia Giver, Emory University;
Edmund K. Waller, MD, PhD, Emory University;
Angela Mortari, University of Minnesota;
Bruce R. Blazar, MD, University of Minnesota;
Leslie S. Kean, MD, PhD, Emory University School of Medicine
Evidence for Expansion of CD21- B Cells with an Exhausted Phenotype in Patients with Active Chronic GvHD
Ahmad Khoder, Imperial College;
Abdullah Alsuliman, Imperial College;
Takuya Sekine, Imperial College;
Kate Stringaris, Imperial College;
Hugues de Lavallade, Imperial College;
Anushruthi Sarvaria, Imperial College;
Donald MacDonald, MD, Imperial College;
Jane F. Apperley, MD, Imperial College;
Katayoun Rezvani, MD, MD Anderson Cancer Center
![[Visit Client Website]](images/banner.gif)